Literature DB >> 28944149

A case of leprosy, erythema nodosum leprosum, and hemophagocytic syndrome: A continuum of manifestations of same agent-host interactions.

Prasan Kumar Panda1, Ramjas Prajapati1, Arvind Kumar1, Manisha Jana2, Pradeep Immanuel3, Pranay Tanwar4, Naveet Wig1.   

Abstract

A young adult man with 4-years history of lepromatous leprosy (received irregularly multidrug therapy) presented with two and half years history of symptoms suggestive of chronic erythema nodosum leprosum (ENL), initially responded to steroids and thalidomide, but later on failed. During the last 2-months, he developed fever, vomiting, and subsequently altered sensorium. On evaluation, he had hepatosplenomegaly, hyponatremia, hyperferritinemia, hemophagocytosis in bone marrow aspiration, lobular panniculitis in skin biopsy, and multiple parenchymal nodules in chest imaging. Hence diagnosis of ENL with hemophagocytic lymphohistiocytic (HLH) syndrome was established and treatment with dexamethasone (10 mg/m2) started. During hospitalization, he developed sinus bradycardia, QT prolongations, recurrent ventricular tachycardia, and moderate systolic dysfunction. The cardiac complications recovered using a temporary pacemaker and were presumed to be due to micronodular cardiac deposition of ENL. This case iterates that ENL can present with varied presentations like asymptomatic lung nodules and storming cardiac complications. More importantly leprosy, ENL, and HLH are a continuum of manifestations of the same agent-host interactions.

Entities:  

Keywords:  Cardiac arrhythmia; hemophagocytic lymphohistiocytic syndrome; lepromatous leprosy; pulmonary nodule; type 2 lepra reaction

Year:  2017        PMID: 28944149      PMCID: PMC5608937          DOI: 10.5582/irdr.2017.01048

Source DB:  PubMed          Journal:  Intractable Rare Dis Res        ISSN: 2186-3644


  8 in total

1.  Clinical course of erythema nodosum leprosum: an 11-year cohort study in Hyderabad, India.

Authors:  Leonor Pocaterra; Suman Jain; Rajgopal Reddy; Syed Muzaffarullah; Obdulita Torres; Sujai Suneetha; Diana N J Lockwood
Journal:  Am J Trop Med Hyg       Date:  2006-05       Impact factor: 2.345

2.  A case of lepromatous leprosy complicated by hemophagocytosis misdiagnosed as hemophagocytic lymphohistiocytosis.

Authors:  Xiang-Zong Zeng; Yi-Ni Wang; Jing-Shi Wang; Lin Wu; Jia Zhang; Qing Wei; Jian Liu; Zhao Wang
Journal:  Int J Infect Dis       Date:  2014-03-18       Impact factor: 3.623

3.  Respiratory system involvement in leprosy.

Authors:  S Kaur; S K Malik; B Kumar; M P Singh; R N Chakravarty
Journal:  Int J Lepr Other Mycobact Dis       Date:  1979-03

Review 4.  Erythema nodosum leprosum in a general hospital.

Authors:  T H Rea; N E Levan
Journal:  Arch Dermatol       Date:  1975-12

5.  Cardiovascular involvement in leprosy patients.

Authors:  K Katoch; G Ramu
Journal:  Nihon Rai Gakkai Zasshi       Date:  1983 Apr-Jun

6.  Hemophagocytic lymphohistiocytosis in leprosy.

Authors:  Liv R Høyvoll; Yngvar Fløisand; Hilde Lang Orrem; Ragnar Gunnarsson; Linn Landrø; Trine Brevig; Peter Gaustad; Ingvild Nordøy
Journal:  Lepr Rev       Date:  2015-12       Impact factor: 0.537

7.  Lymph node abscess and cardiac involvement in a patient with nodular lepromatous leprosy (LL) with erythema nodosum leprosum (ENL): a rare occurrence.

Authors:  Tarang Goyal; Anupam Varshney; S K Bakshi; Veena Sharma
Journal:  Lepr Rev       Date:  2015-03       Impact factor: 0.537

8.  [Leprosy with an unusual course].

Authors:  A Desenfants; E Huguon; Y Polfrit; M Crouzat; V Rouleau; V Chassot; L Besson-Leaud; I Missotte
Journal:  Arch Pediatr       Date:  2012-10-01       Impact factor: 1.180

  8 in total
  1 in total

1.  Rationale use of Thalidomide in erythema nodosum leprosum - A non-systematic critical analysis of published case reports.

Authors:  Pugazhenthan Thangaraju; Sajitha Venkatesan; Meenalotchini Gurunthalingam; Shoban Babu; Tamilselvan T
Journal:  Rev Soc Bras Med Trop       Date:  2020-09-11       Impact factor: 1.581

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.